235 related articles for article (PubMed ID: 28396979)
1. Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.
Sudha T; Bharali DJ; Sell S; Darwish NHE; Davis PJ; Mousa SA
Horm Cancer; 2017 Jun; 8(3):157-165. PubMed ID: 28396979
[TBL] [Abstract][Full Text] [Related]
2. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle.
Li W; Yalcin M; Bharali DJ; Lin Q; Godugu K; Fujioka K; Keating KA; Mousa SA
Sci Rep; 2019 Jun; 9(1):9006. PubMed ID: 31227723
[TBL] [Abstract][Full Text] [Related]
4. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
5. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Sudha T; Bharali DJ; Yalcin M; Darwish NH; Debreli Coskun M; Keating KA; Lin HY; Davis PJ; Mousa SA
Int J Nanomedicine; 2017; 12():1305-1315. PubMed ID: 28243091
[TBL] [Abstract][Full Text] [Related]
7. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α
Rajabi M; Godugu K; Sudha T; Bharali DJ; Mousa SA
Bioconjug Chem; 2019 Dec; 30(12):3087-3097. PubMed ID: 31714064
[TBL] [Abstract][Full Text] [Related]
8. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
[TBL] [Abstract][Full Text] [Related]
10. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
11. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
12. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Yalcin M; Lin HY; Sudha T; Bharali DJ; Meng R; Tang HY; Davis FB; Stain SC; Davis PJ; Mousa SA
Horm Cancer; 2013 Jun; 4(3):176-85. PubMed ID: 23456390
[TBL] [Abstract][Full Text] [Related]
13. Nano Diaminopropane tetrac and integrin αvβ3 expression in different cancer types: Anti-cancer efficacy and Safety.
Godugu K; Sudha T; Davis PJ; Mousa SA
Cancer Treat Res Commun; 2021; 28():100395. PubMed ID: 34034044
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
[TBL] [Abstract][Full Text] [Related]
16. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
17. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Lin HY; Landersdorfer CB; London D; Meng R; Lim CU; Lin C; Lin S; Tang HY; Brown D; Van Scoy B; Kulawy R; Queimado L; Drusano GL; Louie A; Davis FB; Mousa SA; Davis PJ
PLoS Comput Biol; 2011 Feb; 7(2):e1001073. PubMed ID: 21304935
[TBL] [Abstract][Full Text] [Related]
19. Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.
Nana AW; Wu SY; Yang YS; Chin YT; Cheng TM; Ho Y; Li WS; Liao YM; Chen YR; Shih YJ; Liu YR; Pedersen J; Incerpi S; Hercbergs A; Liu LF; Whang-Peng J; Davis PJ; Lin HY
Horm Cancer; 2018 Oct; 9(5):349-360. PubMed ID: 30027502
[TBL] [Abstract][Full Text] [Related]
20. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different
Chin YT; He ZR; Chen CL; Chu HC; Ho Y; Su PY; Yang YSH; Wang K; Shih YJ; Chen YR; Pedersen JZ; Incerpi S; Nana AW; Tang HY; Lin HY; Mousa SA; Davis PJ; Whang-Peng J
Front Endocrinol (Lausanne); 2019; 10():130. PubMed ID: 30915033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
